EUVIMEDEUVIMED entdecken
Crossref

Midkine and TNFSF10 as downstream molecules of type I interferon are involved in the treatment of myelofibrosis

Yaoyao Chen, Fanxiang Yin, Xiaoqian Wang, Huilin Zhang, Ping Tang, Mengjiao Xue, Nannan Sun, Jin Li, Chang Chen, Bingjie Wang, Qingxuan Xin, Juanxia Zhou und 9 weitere

Biochimica et Biophysica Acta (BBA) - General Subjects · 2025

DOI: 10.1016/j.bbagen.2025.130863 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - General Subjects, 2025. Verfasst von Yaoyao Chen und 20 weiteren Autor:innen. Beteiligte Einrichtung: Translational Medical Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China; Department of Laboratory Medicine, The …. Hauptthemen laut MEDLINE: Midkine, Primary Myelofibrosis, Interferon Type I, TNF-Related Apoptosis-Inducing Ligand. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Key Scientific Research Project of Colleges and Universities in Henan Province, National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myelofibrosis (MF), a myeloproliferative neoplasm, remains incurable for most patients. Although some individuals are eligible for allogeneic hematopoietic stem cell transplantation, current therapies generally slow disease progression rather than achieve a cure. In this study, we found that type I interferon (IFN) treatment enhances midkine (MDK) expression, and MDK is involved in the differentiation and maturation of progenitor cells. Notably, MDK treatment drives tumor cells into the cell cycle, thereby increasing the therapeutic effect of busulfan. Furthermore, MDK promotes osteogenic differentiation of mesenchymal stem cells (MSC), contributing to the remodeling of the bone marrow microenvironment. In addition, type I IFN upregulates TNFSF10, leading to tumor cell death through mutual killing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MidkinePrimary MyelofibrosisInterferon Type ITNF-Related Apoptosis-Inducing LigandHumansCell DifferentiationCell CycleOsteogenesisMesenchymal Stem CellsBusulfanUp-RegulationSingle-Cell Gene Expression AnalysisCell Line, Tumor

Stichwörter der Autor:innen

Bone marrow microenvironmentMidkineMyelofibrosisTNFSF10Type-I interferon

Substanzen

MidkineTNFSF10 protein, humanInterferon Type ITNF-Related Apoptosis-Inducing LigandBusulfan

Autor:innen und Institutionen

  • Translational Medical Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China; Department of Laboratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, C…
  • Translational Medical Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Department of Laboratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Translational Medical Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China; Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Department of Laboratory Medicine, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China.

Förderung

  • Key Scientific Research Project of Colleges and Universities in Henan Province
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Zhengzhou University
  • Henan Provincial Science and Technology Research Project

Zitieren

APA

Chen, Y., Yin, F., Wang, X., Zhang, H., Tang, P., Xue, M., Sun, N., Li, J., Chen, C., Wang, B., Xin, Q., Zhou, J., Li, Y., Wang, S., Yan, S., Li, J., Zhu, Y., Qin, B., Yue, B., …, & Guo, R. (2025). Midkine and TNFSF10 as downstream molecules of type I interferon are involved in the treatment of myelofibrosis. Biochimica et Biophysica Acta (BBA) - General Subjects. https://doi.org/10.1016/j.bbagen.2025.130863

Vancouver

Chen Y, Yin F, Wang X, Zhang H, Tang P, Xue M, et al. Midkine and TNFSF10 as downstream molecules of type I interferon are involved in the treatment of myelofibrosis. Biochimica et Biophysica Acta (BBA) - General Subjects. 2025. doi:10.1016/j.bbagen.2025.130863

BibTeX
@article{Chen2025,
  author = {Chen, Yaoyao and Yin, Fanxiang and Wang, Xiaoqian and Zhang, Huilin and Tang, Ping and Xue, Mengjiao and Sun, Nannan and Li, Jin and Chen, Chang and Wang, Bingjie and Xin, Qingxuan and Zhou, Juanxia and Li, Yingmei and Wang, Shuya and Yan, Shaohua and Li, Jiani and Zhu, Yunling and Qin, Bo and Yue, Baohong and Jiang, Yong and Guo, Rongqun},
  title = {Midkine and TNFSF10 as downstream molecules of type I interferon are involved in the treatment of myelofibrosis},
  journal = {Biochimica et Biophysica Acta (BBA) - General Subjects},
  year = {2025},
  doi = {10.1016/j.bbagen.2025.130863}
}
Kostenlos starten →